| Ytd | -37.30% | |
| 1y | -56.11% |
| Open | 1.63 | Prev Close | 1.64 | Low | 1.63 | High | 1.70 | Mkt Cap | 5.07M |
| Vol | 59.00 | Avg Vol | 15.13K | EPS | -1.37 | P/E | -1.20 | Forward P/E | 0.71 |
| Beta | 0.33 | Short Ratio | 0.76 | Inst. Own | 12.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 2.00 | 200-d Avg | 2.30 | 1yr Est | 13.00 |
BMRA News
Auto-renewing Master Services Agreement engages Biomerica's integrated development and manufacturing
Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented
Company and Laboratory Partner Believe Properly Documented Claims Are Positioned for Payment Under E
— Represents Biomerica's First Commercial Entry into the Canadian Market for its Precision, Diagnost
IRVINE, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (“Biomerica” or t
Biomerica (NASDAQ: BMRA - Get Free Report) is anticipated to post its results after the market close
IRVINE, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider
UK Market Entry: MHRA registration authorizes hp+detect™ for commercial sale in Great Britain Active
Key Highlights Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1
Biomerica, Inc. (NASDAQ: BMRA - Get Free Report)'s stock price crossed below its 200-day moving aver
IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider
Operating Expenses Decline 4% Year-to-Date Balance Sheet Strengthens and Working Capital Improves by
Biomerica, Inc. (NASDAQ: BMRA - Get Free Report) saw a significant growth in short interest during t
Biomerica, Inc. (NASDAQ: BMRA - Get Free Report)'s stock price passed below its 200-day moving avera
IRVINE, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider
Biomerica, Inc. (NASDAQ: BMRA - Get Free Report)'s share price passed below its 200-day moving avera
Authorization Covers Multiple Screening Tests for Cancer and Chronic Disease Risk Detection • Portfo
IRVINE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider
IRVINE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider
- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation's Most Trusted
On Thursday, 369 companies hit new 52-week lows.
During Thursday's session, 406 companies made new 52-week lows.